Perbedaan Organon Pharma Indonesia Tbk. dan Pabrik Kertas Tjiwi Kimia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Pabrik Kertas Tjiwi Kimia Tbk. diperdagangkan di Rp7.850 (kapitalisasi pasar 24,83 T, volume 24 jam 4,14 jt). Perbedaan utamanya: Pabrik Kertas Tjiwi Kimia Tbk. jauh lebih besar — sekitar 237,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TKIM | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 24,83 T |
Volume | — | 4,14 jt |
Lot | — | 41,35 rb |
Perputaran | — | 32,31 M |
Harga Rata-rata | — | 7.813,32 |
Nilai Transaksi | — | 32,31 M |
Harga Ekuilibrium Indikatif | — | 7.850 |
Volume Ekuilibrium Indikatif | — | 421 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Pabrik Kertas Tjiwi Kimia Tbk (the Company) was established in 1972 under the name of PT Tjiwi Kimia and was later renamed to become PT Pabrik Kertas Tjiwi Kimia in 1974. The total production capacity as of December 31, 1999 for the printing and writing paper stood at 1.014.000 tonnes per annum, packaging and converted products at 78.000 tonnes per annum and stationery at 275.000 tonnes per annum.The Company started its commercial production in 1977.
Selengkapnya di halaman TKIM →